This inventor holds 1 USPTO granted patent and 1 published patent application and 7 EPO patents. Top assignee: Intel Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Wei Chen - Innovator in Pharmaceutical Research
Introduction
Wei Chen is an inventor based in Fremont, California. He has made contributions to the field of pharmaceutical research, particularly in the development of inhibitors for specific kinases. Although he currently holds no granted patents, his work is significant in advancing medical science.
Latest Patent Applications
Wei Chen's notable patent application is titled "Synthesis of a Bruton's Tyrosine Kinase Inhibitor." This application describes the synthesis of Bruton's tyrosine kinase (Btk) inhibitor 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one. This work showcases his innovative approach to developing potential therapeutic agents.
Conclusion
Wei Chen's contributions to pharmaceutical research highlight his dedication to innovation in the field. His work, particularly in synthesizing kinase inhibitors, reflects the ongoing efforts to improve medical treatments.